NGS and personalized medicine: The role of data interpretation
The advance of Next Generation Sequencing (NGS) technology has enabled researchers to generate genome wide data in unprecedented quality and quantity. Genomatix offers solutions and services for the entire course of analysis from first level mapping to integrating multiple results with copious high-quality data background. Our technologies for visualization and interpretation enable scientists world-wide to turn their data into meaningful results, making NGS the perfect vehicle to enable personalized medicine
Genomatix is a partner in the €30M European BLUEPRINT epigenomics consortium. Genomatix will develop visualization interfaces for BLUEPRINT.
» read more
Genomatix is among the partners of the European EURenOmics research project about rare renal diseases.
» read more on the project webpage
Genomatix will give a lunch seminar and host a 2 day workshop (both on NGS data analysis) at the qPCR & NGS 2013 Event in Weihenstephan.
» read more on the event